July 5th 2022

Published in CellPress iScience: Computed Tomography and [18 F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

Published in CellPress iScience: Computed Tomography and [18 F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates 

The CARE partners Institut National De La Santé Et De La Recherche Médicale – Vaccine Research Institute (INSERM-VRI) and Commissariat À L’énergie Atomique Et Aux Énergies Alternatives (CEA) published a paper reporting how PET and CT imaging provide an additional readout to assess therapy efficacy as demonstrated through monitoring the early phase of COVID-19 in 76 SARS-CoV-2 infected macaques. The comparison of CT and PET data from previous COVID-19 treatments or vaccines tested in NHP, to this large cohort of untreated animals demonstrated the value of in vivo imaging in preclinical trials.

To learn more, click here: Computed Tomography and [18 F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates